A Clinical Trial to Evaluate the Effects of Super Lungs Liquid Drops on Respiratory Comfort, Airway Soothing, and Overall Well-Being

This is a single-group, open-label, fully decentralized (virtual) clinical trial evaluating the effects of Super Lungs Liquid Drops on respiratory comfort, airway soothing, and overall well-being in generally healthy adults aged 18-65 who experience bothersome respiratory symptoms. All 35 enrolled participants will receive the active study product and self-administer 2 mL of the drops daily (two full droppers of 1 mL each, once daily with the first meal of the day) for 12 weeks.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Coughing Cough Pathological Conditions, Signs and Symptoms Respiration Disorders Respiratory Tract Diseases Signs and Symptoms Signs and Symptoms, Respiratory Throat Irritation

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Citruslabs

Las Vegas, Nevada, 89118, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adults aged 18-65 years.
Over the past two months, has experienced bothersome coughing on a weekly basis.
Anyone who has experienced issues with at least two of the following over the past four weeks: chest tightness or congestion; persistent throat irritation or itchiness; excess mucus or phlegm buildup.
Generally healthy, without any uncontrolled chronic disease.
Willing to maintain their current diet, sleep pattern, and activity levels for the duration of the trial.
Resides in the United States.
Has access to the internet and a device (smartphone, tablet, or computer) capable of completing online questionnaires.
Willing to follow the study protocol and complete all required assessments.

Exclusion criteria

Anyone with a known allergy or sensitivity to any of the study product ingredients.
Anyone with a known allergy to plants in the Asteraceae/Compositae family.
Women who are pregnant, breastfeeding, or planning to become pregnant during the study period.
Anyone currently taking immunosuppressant medications (e.g., cyclosporine, methotrexate, biologics such as adalimumab or infliximab).
Anyone with a diagnosed autoimmune disorder (e.g., lupus, rheumatoid arthritis, multiple sclerosis).
Anyone with uncontrolled hypertension or currently taking antihypertensive medications, diuretics, or corticosteroids.
Anyone currently taking anticoagulant or antiplatelet medications (e.g., warfarin, heparin, clopidogrel).
Anyone with a chronic health condition that could impact their participation in this study, such as cancer, mental health disorders, a history of serious illness in the last three months, a history of substance abuse, or planned surgery during the study period.
Anyone with a history of alcohol use disorder or currently in alcohol recovery.
Anyone currently participating in another research study or who plans to participate in another study during the study period. (

Treatment and study plan

Super Lungs Liquid Drops

Dietary Supplement

All 35 participants receive Super Lungs Liquid Drops at 2 mL daily (two full droppers of 1 mL each), administered once daily with the first meal of the day, for 12 weeks.

Primary outcomes

Respiratory comfort

Time frame: Baseline, Week 2, Week 4, Week 8, and Week 12

Change in self-reported respiratory comfort assessed by questionnaires.
Normal airway function

Time frame: Baseline, Week 2, Week 4, Week 8, and Week 12

Change in self-reported normal airway function assessed by questionnaires.

Sponsors and collaborators

Lead sponsor

SuperBonsai Inc.

Industry

Collaborators

Citruslabs

Registry information

Important dates

Study start: 2026
Primary completion: 2026
Study completion: 2026
First posted: Jul 9, 2026
Registry last updated: Jul 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting